The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

In many cases, it's not until memory problems start creeping up that most people learn they have Alzheimer's disease. By then, the disease may already be progressing, leaving limited options for ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether memory problems ...

Scientists at CSIRO, Australia's national science agency, have identified simpler and less invasive methods to improve ...

Simple blood test gets green light by FDA to improve early detection of Alzheimer’s disease - Millions of Americans are ...

A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...

The availability of a rule-in-rule-out test for Alzheimer’s disease in primary care settings is likely to drive efficiencies throughout the care continuum.

This comes at the heel of FDA's nod for Fujirebio Diagnostics' blood test Lumipulse in May, the first such device to get ...

The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...

Labcorp announced it will offer the nation's first blood test cleared by the FDA for the initial assessment in Alzheimer's ...

A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...